Efficacy and safety of anlotinib for triple-negative breast cancer with brain metastases
Anlotinib demonstrated encouraging efficacy and manageable toxicity in the treatment of TNBC patients with brain metastases who had failed standard treatment.
Authors
- Ping Sun (ORCID: https://orcid.org/0000-0003-2776-8530)
- Ming Li (ORCID: https://orcid.org/0000-0001-6291-9328)
- Zeyu Liu (ORCID: https://orcid.org/0000-0003-4377-1780)
- Ziyi Zhao (ORCID: https://orcid.org/0000-0003-1871-5197)
- Aina Liu (ORCID: https://orcid.org/0000-0002-2038-5820)
Institutions
- Qingdao University (CN)
- Yuhuangding Hospital (CN)
- Affiliated Hospital of Qingdao University (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2024-10-03
- DOI
- https://doi.org/10.3389/fonc.2024.1439984
- Citations
- 1
- Primary Topic
- Brain Metastases and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.42